These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30191805)

  • 61. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals.
    Wallmann J
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():81-6. PubMed ID: 16530479
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecules that Inhibit Bacterial Resistance Enzymes.
    Liu Y; Li R; Xiao X; Wang Z
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30583527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Review of antibiotic resistance in China and its environment.
    Qiao M; Ying GG; Singer AC; Zhu YG
    Environ Int; 2018 Jan; 110():160-172. PubMed ID: 29107352
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical importance and public health concerns for the emergence of antibiotic resistant organisms in the human intestinal microflora.
    Shlaes DM
    Vet Hum Toxicol; 1993; 35 Suppl 1():24-7. PubMed ID: 8236754
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antimicrobial resistance among clinically relevant bacterial isolates in Accra: a retrospective study.
    Mohammed J; Hounmanou YMG; Thomsen LE
    BMC Res Notes; 2018 Apr; 11(1):254. PubMed ID: 29695265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria.
    Hwang IY; Koh E; Kim HR; Yew WS; Chang MW
    Drug Resist Updat; 2016 Jul; 27():59-71. PubMed ID: 27449598
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.
    Møller JK
    Dan Med Bull; 1990 Jun; 37(3):263-74. PubMed ID: 2192838
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Establishment of the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS): A Pilot Project on Poultry Farms, Slaughterhouses and Retail Market.
    Donado-Godoy P; Castellanos R; León M; Arevalo A; Clavijo V; Bernal J; León D; Tafur MA; Byrne BA; Smith WA; Perez-Gutierrez E
    Zoonoses Public Health; 2015 Apr; 62 Suppl 1():58-69. PubMed ID: 25903494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bacterial drug resistance in meat animals: a review.
    Okolo MI
    Int J Zoonoses; 1986 Sep; 13(3):143-52. PubMed ID: 3549599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bacterial resistance to ciprofloxacin in Greece: results from the National Electronic Surveillance System. Greek Network for the Surveillance of Antimicrobial Resistance.
    Vatopoulos AC; Kalapothaki V; Legakis NJ
    Emerg Infect Dis; 1999; 5(3):471-6. PubMed ID: 10341191
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations.
    Hughes JM; Tenover FC
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S131-5. PubMed ID: 8994792
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microbes have the last word. A drastic re-evaluation of antimicrobial treatment is needed to overcome the threat of antibiotic-resistant bacteria.
    Davies J
    EMBO Rep; 2007 Jul; 8(7):616-21. PubMed ID: 17603533
    [No Abstract]   [Full Text] [Related]  

  • 74. Global antimicrobial resistance: a complex and dire threat with few definite answers.
    Islam S; Aldstadt J; Aga D
    Trop Med Int Health; 2019 Jun; 24(6):658-662. PubMed ID: 30884021
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille, France.
    Abat C; Chaudet H; Colson P; Rolain JM; Raoult D
    Emerg Infect Dis; 2015 Aug; 21(8):1302-10. PubMed ID: 26196165
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Surveillance and control of asymptomatic carriers of drug-resistant bacteria.
    Jamrozik E; Selgelid MJ
    Bioethics; 2019 Sep; 33(7):766-775. PubMed ID: 31423608
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Laboratory informatics capacity for effective antimicrobial resistance surveillance in resource-limited settings.
    Turner P; Rupali P; Opintan JA; Jaoko W; Feasey NA; Peacock SJ; Ashley EA
    Lancet Infect Dis; 2021 Jun; 21(6):e170-e174. PubMed ID: 33865461
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally.
    O'Brien TF
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S2-8. PubMed ID: 8994775
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A conceptual framework for the environmental surveillance of antibiotics and antibiotic resistance.
    Huijbers PMC; Flach CF; Larsson DGJ
    Environ Int; 2019 Sep; 130():104880. PubMed ID: 31220750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The application of information technology to regional, national, and global surveillance of antimicrobial resistance.
    Sahm DF; Thornsberry C; Karlowsky JA
    Curr Pharm Des; 2003; 9(12):969-74. PubMed ID: 12678862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.